ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

EVGN Evogene Ltd

0.70258
-0.00292 (-0.41%)
최종 업데이트: 01:57:30
15분 지연
기업명 주식 심볼 시장 주식 타입
Evogene Ltd EVGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.00292 -0.41% 0.70258 01:57:30
개장가 저가 고가 종가 전일 종가
0.70 0.6706 0.7315 0.7055
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202420:00PRNUSBiomica to Present at the American Society of Clinical..
11/04/202420:00PRNUSBiomica to Present at Digestive Disease Week (DDW)..
02/04/202420:00PRNUSEvogene and The Kitchen FoodTech Hub by Strauss Group..
28/03/202422:00PRNUSEvogene Announces Filing of Annual Report on Form 20-F
20/03/202422:00PRNUSEvogene Reports Receipt of Nasdaq Minimum Bid Price..
19/03/202422:00PRNUSBayer AG and Lavie Bio Continue for Second Year of..
13/03/202422:00PRNUSLavie Bio and Ceres Global Ag Corp. Collaborate to Include..
07/03/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/03/202421:00PRNUSEvogene Reports Fourth Quarter and Full Year 2023 Financial..
06/03/202421:00PRNUSAgPlenus Achieves Milestone in Collaboration with Corteva to..
05/03/202421:00PRNUSCasterra Announces New Agreements with Seed Producers in..
01/03/202421:03EDGAR2Form F-3 - Registration statement by foreign private issuers
28/02/202421:00PRNUSLavie Bio Successfully Secures Second Half Advance Payment..
26/02/202421:00PRNUSEvogene Schedules Fourth Quarter 2023 Financial Results..
22/02/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/02/202421:00PRNUSAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as..
21/02/202421:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/02/202421:00PRNUSAgPlenus Announces Licensing & Collaboration Agreement with..
20/02/202421:00PRNUSSyngenta and Lavie Bio Announce Partnership to Discover and..
15/02/202410:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/02/202421:08PRNUSEvogene and Verb Biotics Enter Collaboration Agreement to..
23/01/202421:00PRNUSBiomica CEO Set to Engage in Panel Discussion at 8th Annual..
17/01/202421:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/01/202421:00PRNUSBiomica Successfully Completes Phase I Trial Enrollment for..
09/01/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202321:00PRNUSBiomica CEO Set to Attend JP Morgan Healthcare Week in San..
19/12/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202321:00PRNUSCasterra Appoints New CEO and Expands Team to Drive Growth..
05/12/202321:00PRNUSLavie Bio Announces a Distribution Agreement with WinField..
28/11/202321:00PRNUSLavie Bio Announces Expansion of its Bio-Inoculant Product..
15/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202321:00PRNUSEvogene Reports Third Quarter 2023 Financial Results
08/11/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202320:00PRNUSEvogene Schedules Third Quarter 2023 Financial Results..
31/10/202320:00PRNUSColors Farm, Evogene and Ben-Gurion University Collaborate..
18/10/202320:00PRNUSEvogene Provides Operational Update Amidst Current Security..
27/09/202320:00PRNUSCasterra Delivers First Shipment of Castor Seeds to Africa
21/09/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/09/202320:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/09/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/08/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/08/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/08/202320:00PRNUSEvogene Reports Second Quarter 2023 Financial Results
15/08/202320:00PRNUSBiomica Opens Second Site to Advance Its Immuno-Oncology..
08/08/202320:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/08/202320:00PRNUSEvogene Schedules Second Quarter 2023 Financial Results..
25/07/202320:00PRNUSEvogene's ChemPass AI Tech-Engine is Introduced with New..
19/07/202320:00PRNUSBiomica Announces Interim Positive Results from Pre-Clinical..
19/07/202303:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/07/202321:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

Delayed Upgrade Clock